Study Title: A Randomized Phase III Trial of Chemo-Immunotherapy vs Immunotherapy Alone for the Vulnerable older adult with Advanced Non-Small Cell Lung Cancer: The ACHIEVE Study
For more information about the trial above please contact the study team:Medical University of South CarolinaPrincipal Investigator, Christopher Rangel, at rangelc@musc.edu.Study Coordinator, Alec Schumpp, at schumpp@musc.edu.Trial opened at the following institutions: Medical University of South Carolina